OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 9.34 EUR -3.81% Market Closed
Market Cap: 203.2m EUR
Have any thoughts about
OSE Immunotherapeutics SA?
Write Note

Relative Value

The Relative Value of one OSE stock under the Base Case scenario is 23.92 EUR. Compared to the current market price of 9.34 EUR, OSE Immunotherapeutics SA is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OSE Relative Value
Base Case
23.92 EUR
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
19
Median 3Y
6.1
Median 5Y
6.1
Industry
8.1
Forward
2.8
vs History
1
vs Industry
Median 3Y
-5.3
Median 5Y
-7.8
Industry
23
Forward
5.1
vs History
15
vs Industry
Median 3Y
-6
Median 5Y
-6.3
Industry
23.4
vs History
31
vs Industry
Median 3Y
-3.7
Median 5Y
-4.5
Industry
27.3
vs History
53
vs Industry
14
Median 3Y
2.9
Median 5Y
2.7
Industry
2.6
vs History
80
vs Industry
15
Median 3Y
6.3
Median 5Y
6.2
Industry
8.1
Forward
2.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
1
vs Industry
Median 3Y
-7.4
Median 5Y
-8.6
Industry
4.3
Forward
2.9
vs History
1
vs Industry
Median 3Y
-6.3
Median 5Y
-7.6
Industry
3.8
Forward
2.5
vs History
15
vs Industry
Median 3Y
-6.9
Median 5Y
-6.8
Industry
6
vs History
15
vs Industry
Median 3Y
-6.8
Median 5Y
-6.7
Industry
3.8
vs History
17
vs Industry
41
Median 3Y
2.2
Median 5Y
2.1
Industry
4.8

Multiples Across Competitors

OSE Competitors Multiples
OSE Immunotherapeutics SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
OSE Immunotherapeutics SA
PAR:OSE
204.6m EUR 2.4 4.4 3 3.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 380 957.8 -177 666.1 -215 743.3 -213 281.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 5.4 59.5 14.9 22.9
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 4.9 38 17.7 33.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 11.9 -263.2 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 4.2 939 10.4 10.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 884.6 -480.9 -523.7 -509.7
AU
CSL Ltd
ASX:CSL
138.5B AUD 6.1 34.3 21.1 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 6.5 19.4 17.9 19.9
US
Seagen Inc
F:SGT
39.3B EUR 18.2 -55.7 -59.8 -54
NL
argenx SE
XBRU:ARGX
33.4B EUR 18.2 -127.9 -102.8 -74.9
P/E Multiple
Earnings Growth
FR
OSE Immunotherapeutics SA
PAR:OSE
Average P/E: 182.4
4.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -177 666.1 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
939
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -480.9 N/A
AU
CSL Ltd
ASX:CSL
34.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9 N/A
EV/EBITDA Multiple
EBITDA Growth
FR
OSE Immunotherapeutics SA
PAR:OSE
Average EV/EBITDA: 15.9
3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 743.3 N/A
US
Abbvie Inc
NYSE:ABBV
14.9
28%
US
Amgen Inc
NASDAQ:AMGN
17.7
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.7 N/A
AU
CSL Ltd
ASX:CSL
21.1
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -102.8 N/A
EV/EBIT Multiple
EBIT Growth
FR
OSE Immunotherapeutics SA
PAR:OSE
Average EV/EBIT: 20.6
3.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 281.4 N/A
US
Abbvie Inc
NYSE:ABBV
22.9
88%
US
Amgen Inc
NASDAQ:AMGN
33.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -509.7 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -74.9 N/A

See Also

Discover More
Back to Top